{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T22:24:46Z","timestamp":1774736686049,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtha.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:51:35Z","timestamp":1716490295000},"page":"2184-2194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The historical origins of modern international normalized ratio targets"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-1484","authenticated-orcid":false,"given":"Sheharyar","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Hirsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-4427","authenticated-orcid":false,"given":"Rita","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.05.013_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.10967","article-title":"Prevalence and predictability of low-yield inpatient laboratory diagnostic tests","volume":"2","author":"Xu","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jtha.2024.05.013_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1538-7836.2004.00775.x","article-title":"International normalized ratios (INR): the first 20 years","volume":"2","author":"Poller","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1537-2995.1986.26687043615.x","article-title":"A\u00a0critical survey of fresh-frozen plasma use","volume":"26","author":"Blumberg","year":"1986","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/vox.13355","article-title":"Plasma transfusion practices: a multicentre electronic audit","volume":"117","author":"Khandelwal","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2024.05.013_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/vox.12386","article-title":"Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital","volume":"111","author":"Shander","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2024.05.013_bib6","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2044.2010.06538.x","article-title":"Blood transfusion and the anaesthetist: management of massive haemorrhage","volume":"65","author":"Thomas","year":"2010","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jtha.2024.05.013_bib8","first-page":"132","article-title":"Recommendations for the transfusion of plasma and platelets","volume":"7","author":"Liumbruno","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2024.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/cc5781","article-title":"Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: a European guideline","volume":"11","author":"Spahn","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2024.05.013_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/jth.15756","article-title":"The international normalized ratio-great for prediction of bleeding in patients taking vitamin K antagonists, useless for prediction of bleeding in patients with chronic liver disease","volume":"20","author":"Giannini","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib11","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1537-2995.2006.00891.x","article-title":"Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities","volume":"46","author":"Abdel-Wahab","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review","volume":"45","author":"Segal","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib13","doi-asserted-by":"crossref","first-page":"E1135","DOI":"10.1503\/cmaj.220629","article-title":"International normalized ratio and activated partial thromboplastin time testing","volume":"194","author":"Chornenki","year":"2022","journal-title":"CMAJ"},{"key":"10.1016\/j.jtha.2024.05.013_bib14","series-title":"StatPearls","article-title":"Prothrombin time","author":"Yang","year":"2022"},{"key":"10.1016\/j.jtha.2024.05.013_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.05.013_bib16","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(02)07282-3","article-title":"Interpretation of the international normalised ratio in patients with liver disease","volume":"359","author":"Deitcher","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.05.013_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5045\/kjh.2012.47.4.298","article-title":"Complications following an unnecessary peri-operative plasma transfusion and literature review","volume":"47","author":"Raval","year":"2012","journal-title":"Korean J Hematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.013_bib21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.5811\/westjem.2018.7.37893","article-title":"The misunderstood coagulopathy of liver disease: a review for the acute setting","volume":"19","author":"Harrison","year":"2018","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib22","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc10129","article-title":"A\u00a0national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time","volume":"15","author":"Stanworth","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2024.05.013_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tracli.2008.03.008","article-title":"Evidence for indications of fresh frozen plasma","volume":"14","author":"Stanworth","year":"2007","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.jtha.2024.05.013_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000542-200607000-00030","article-title":"Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies","volume":"105","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2024.05.013_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000542-199603000-00032","article-title":"Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy","volume":"84","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2024.05.013_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u221651.w8161","article-title":"REDucing unnecessary coagulation testing in the emergency department (REDUCED)","volume":"6","author":"Fralick","year":"2017","journal-title":"BMJ Qual Improv Rep"},{"key":"10.1016\/j.jtha.2024.05.013_bib27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1097\/01.CCM.0000186745.53059.F0","article-title":"Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy","volume":"33","author":"Dara","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib28","article-title":"Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis [Internet]","author":"Membe","year":"2011","journal-title":"Ottawa (ON): Canadian Agency for Drugs and Technologies in Health"},{"key":"10.1016\/j.jtha.2024.05.013_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000441-193510000-00009","article-title":"A\u00a0study of the coagulation defect in hemophilia and in jaundice","volume":"190","author":"Quick","year":"1935","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jtha.2024.05.013_bib30","series-title":"A\u00a0history of blood coagulation","author":"Owen","year":"2001"},{"key":"10.1016\/j.jtha.2024.05.013_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0021-9258(18)51377-6","article-title":"Studies on the hemorrhagic sweet clover disease. 5. Identification and synthesis of the hemorrhagic agent","volume":"138","author":"Stahmann","year":"1941","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.013_bib32","first-page":"1325","article-title":"Vitamin K antagonists: the first 50 years","volume":"117","author":"Griminger","year":"1987","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jtha.2024.05.013_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/ed046p561","article-title":"The historical and current interest in coumarin","volume":"46","author":"Abernethy","year":"1969","journal-title":"J\u00a0Chem Educ"},{"key":"10.1016\/j.jtha.2024.05.013_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.19.1.97","article-title":"The discovery of dicumarol and its sequels","volume":"19","author":"Link","year":"1959","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.05.013_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jama.1942.02830480013004","article-title":"A\u00a0preparation from spoiled sweet clover: [3, 3\u2032-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: a clinical study","volume":"120","author":"Allen","year":"1942","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.05.013_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(54)90838-7","article-title":"Myocardial infarction and its treatment with anticoagulants: summary of findings in 1031 cases","volume":"263","author":"Wright","year":"1954","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.05.013_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-8703(48)90278-6","article-title":"Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction: a progress report on the statistical analysis of the first 800 cases studied by this committee","volume":"36","author":"Wright","year":"1948","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2024.05.013_bib38","first-page":"44","article-title":"The president who swallowed rat poison: preventing the next heart attack","volume":"15","author":"Fenske","year":"2004","journal-title":"Patient Care"},{"key":"10.1016\/j.jtha.2024.05.013_bib39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1160\/th14-05-0433","article-title":"Solving the mystery of excessive warfarin-induced bleeding: a personal historical perspective","volume":"112","author":"Hirsh","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcp\/47.1.40","article-title":"1963 prothrombin time test survey, College of American pathologists, Standards Committee, Subcommittee on Coagulation","volume":"47","author":"Mule","year":"1967","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2024.05.013_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ajcp\/53.3.348","article-title":"Standardization of laboratory tests for controlling anticoagulent therapy","volume":"53","author":"Zucker","year":"1970","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2024.05.013_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.1982.00479.x","article-title":"Dosage and control of oral anticoagulants: an international collaborative survey","volume":"51","author":"Poller","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.2.5408.565","article-title":"Standardization of anticoagulant treatment: the Manchester regional thromboplastin scheme","volume":"2","author":"Poller","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.jtha.2024.05.013_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1987.00385.x-i1","article-title":"Thromboplastin and oral anticoagulant control","volume":"66","author":"Lewis","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.294.6581.1184","article-title":"Laboratory control of oral anticoagulants","volume":"294","author":"Poller","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jtha.2024.05.013_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/bmj.1.5532.84","article-title":"Standardization of the one-stage prothrombin time for the control of anticoagulant therapy","volume":"1","author":"Biggs","year":"1967","journal-title":"Br Med J"},{"key":"10.1016\/j.jtha.2024.05.013_bib47","first-page":"238","article-title":"Calibration of reference thromboplastins and standardisation of the prothrombin time ratio","volume":"50","author":"Kirkwood","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1987.00370040151026","article-title":"Is the dose of warfarin prescribed by American physicians unnecessarily high?","volume":"147","author":"Hirsh","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib49","first-page":"1041","article-title":"The \"therapeutic range\" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations","volume":"105","author":"Bailey","year":"1971","journal-title":"CMAJ"},{"key":"10.1016\/j.jtha.2024.05.013_bib50","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1378\/chest.89.2_Supplement.11S","article-title":"\u201cTherapeutic range\u201d for oral anticoagulant therapy","volume":"89","author":"Hirsh","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib51","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(59)91464-3","article-title":"Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur","volume":"2","author":"Sevitt","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.05.013_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2024.05.013_bib53","first-page":"335","article-title":"Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council","volume":"1","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/j.jtha.2024.05.013_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.1973.03220340034009","article-title":"Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial","volume":"225","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.05.013_bib55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.1.6108.272","article-title":"Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis","volume":"1","author":"Taberner","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.jtha.2024.05.013_bib56","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198212303072704","article-title":"Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis","volume":"307","author":"Hull","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis","volume":"306","author":"Hull","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.1983.03330270038029","article-title":"Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding","volume":"249","author":"Francis","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.05.013_bib59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0167-5273(84)90086-X","article-title":"The pathology of the heart following long-term anticoagulant therapy in elderly patients after myocardial infarction. The Dutch sixty-plus reinfarction study","volume":"5","author":"de Vries","year":"1984","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2024.05.013_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V61.1.210c.210c","article-title":"Standardization in the laboratory control of oral anticoagulant therapy","volume":"61","author":"Lewis","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.013_bib61","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0038-1665293","article-title":"A\u00a0collaborative calibration study of reference materials for thromboplastins","volume":"50","author":"Hermans","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jcp.38.2.133","article-title":"ICSH\/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardization in Haematology and International Committee on Thrombosis and Haemostasis","volume":"38","year":"1985","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jtha.2024.05.013_bib63","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.89.2_Supplement.1S","article-title":"Introduction","volume":"89","author":"Dalen","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib64","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1378\/chest.89.2_Supplement.2S","article-title":"Rules of evidence and clinical recommendations on the use of antithrombotic agents","volume":"89","author":"Sackett","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib65","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1378\/chest.89.2_Supplement.16S","article-title":"Hemorrhagic complications of long-term anticoagulant therapy","volume":"89","author":"Levine","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib66","first-page":"1S","article-title":"American College of Chest Physicians and the National Heart, Lung and Blood Institute","volume":"89","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.1969.tb00376.x","article-title":"The interpretation of prothrombin results: a national survey","volume":"16","author":"Poller","year":"1969","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib68","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1378\/chest.89.2_Supplement.82S","article-title":"Cerebral embolism","volume":"89","author":"Sherman","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib69","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1378\/chest.89.2_Supplement.75S","article-title":"Antithrombotic therapy in peripheral vascular disease","volume":"89","author":"Genton","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib70","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1378\/chest.89.2_Supplement.68S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"89","author":"Dunn","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib71","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1378\/chest.89.2_Supplement.54S","article-title":"Antithrombotic agents in coronary artery disease","volume":"89","author":"Resnekov","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib72","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1378\/chest.89.2_Supplement.46S","article-title":"Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts","volume":"89","author":"Stein","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib73","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1378\/chest.89.2_Supplement.36S","article-title":"Antithrombotic therapy in valvular heart disease","volume":"89","author":"Levine","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib74","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.89.2_Supplement.26S","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"89","author":"Hyers","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib75","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/1076029618772353","article-title":"International normalized ratio relevance to the observed coagulation abnormalities in warfarin treatment and disseminated intravascular coagulation","volume":"24","author":"Walborn","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib76","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A\u00a0comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib77","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.05.013_bib78","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJM199106273242606","article-title":"Oral anticoagulant drugs","volume":"324","author":"Hirsh","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib79","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jth.15743","article-title":"Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study","volume":"20","author":"Afzal","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7933.2008.02827.x","article-title":"The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions","volume":"6","author":"Tripodi","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.21732","article-title":"The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end-stage liver disease calculation","volume":"46","author":"Tripodi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.05.013_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.1987.tb02359.x","article-title":"Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient","volume":"67","author":"Ciavarella","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.013_bib83","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/CCM.0000000000000981","article-title":"An international normalized ratio\u2013based definition of acute traumatic coagulopathy is associated with mortality, venous thromboembolism, and multiple organ failure after injury","volume":"43","author":"Peltan","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2024.05.013_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0749-0704(03)00089-7","article-title":"Coagulation defects in trauma patients: etiology, recognition, and therapy","volume":"20","author":"DeLoughery","year":"2004","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jtha.2024.05.013_bib85","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2106\/JBJS.18.00771","article-title":"Revisiting the international normalized ratio (INR) threshold for complications in primary total knee arthroplasty: an analysis of 21,239 cases","volume":"101","author":"Rudasill","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jtha.2024.05.013_bib86","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/apt.16078","article-title":"Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis","volume":"52","author":"Kovalic","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jtha.2024.05.013_bib87","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/trf.16508","article-title":"Plasma trial: pilot randomized clinical trial to determine safety and efficacy of plasma transfusions","volume":"61","author":"Carson","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib88","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0310057X0303100403","article-title":"Cryoprecipitate for the correction of coagulopathy associated with liver disease","volume":"31","author":"French","year":"2003","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jtha.2024.05.013_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/trf.12750","article-title":"Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME)","volume":"55","author":"M\u00fcller","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.05.013_bib90","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood-2023-185358","article-title":"Assessing pre-operative bleeding risk using INR\/aPTT: a systematic review","volume":"142","author":"Rahhal","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.013_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11239-015-1235-1","article-title":"Preoperative INR and postoperative major bleeding and mortality: a retrospective cohort study","volume":"41","author":"Tamim","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.05.013_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2006.07.002","article-title":"Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma","volume":"120","author":"Yuan","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.05.013_bib93","series-title":"StatPearls. Treasure Island (FL)","article-title":"Protein C and S","author":"Padda","year":"2023"},{"key":"10.1016\/j.jtha.2024.05.013_bib94","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.14683","article-title":"Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC","volume":"18","author":"Gresele","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib95","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/rth2.12339","article-title":"An illustrated review of bleeding assessment tools and common coagulation tests","volume":"4","author":"Elbaz","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12959-021-00327-1","article-title":"Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article","volume":"19","author":"Onundarson","year":"2021","journal-title":"Thrombosis J"},{"key":"10.1016\/j.jtha.2024.05.013_bib97","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.05.013_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.013_bib99","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis","volume":"161","author":"O'Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2024.05.013_bib100","author":"Bent"},{"key":"10.1016\/j.jtha.2024.05.013_bib101","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.05.013_bib102","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","volume":"30","author":"Patel","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jtha.2024.05.013_bib103","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000856","article-title":"Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: persistent gaps and areas of consensus in a multispecialty Delphi","author":"Tapper","year":"2024","journal-title":"Hepatology"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T02:06:54Z","timestamp":1721700414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1538783624002964"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.013","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The historical origins of modern international normalized ratio targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}